Nerve growth factor effect on human primary fibroblastic-keratocytes: Possible mechanism during corneal healing

Experimental Eye Research

Volumn 83, Issue 4, 2006, Pages 747-757

  Micera, Alessandra ^a,b   Lambiase, Alessandro ^a   Puxeddu, Ilaria ^b   Aloe, Luigi ^c   Stampachiacchiere, Barbara ^a   Levi Schaffer, Francesca ^b   Bonini, Sergio ^c,d   Bonini, Stefano ^a  

^a UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^c CNR   (Italy)

^d IRCCS SAN RAFFAELE PISANA   (Italy)

Author keywords

corneal healing; fibroblastic keratocyte; metalloproteinases; NGF; tissue repair

Indexed keywords

COLLAGEN GEL; CYTOKINE; GROWTH FACTOR; NERVE GROWTH FACTOR RECEPTOR; PROTEIN P75; PROTEIN TYROSINE KINASE A; STROMELYSIN;

ARTICLE; AUTOIMMUNE DISEASE; CELL DIFFERENTIATION; CELL MIGRATION; CONTROLLED STUDY; CORNEA CELL; CORNEA INJURY; CORNEA ULCER; ENZYME ACTIVITY; EPITHELIUM CELL; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; MYOFIBROBLAST; PLEIOTROPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; WOUND HEALING;

CELL DIFFERENTIATION; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; CORNEA; DOSE-RESPONSE RELATIONSHIP, DRUG; FIBROBLASTS; HUMANS; NERVE GROWTH FACTOR; RECEPTOR, NERVE GROWTH FACTOR; RECEPTOR, TRKA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; WOUND HEALING;

EID: 33748162256     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exer.2006.03.010     Document Type: Article

References (42)

1. Andresen J.L., Ledet T., and Ehlers N. Keratocyte migration and peptide growth factors: the effect of PDGF, bFGF, EGF, IGF-I, aFGF and TGF-beta on human keratocyte migration in a collagen gel. Curr. Eye Res. 16 (1997) 605-613
2. Amstrong D.J., Hiscott P., Batterbury M., and Kaye S. Keratocyte matrix interactions and thrombospondin 2. Mol. Vis. 9 (2003) 74-79
3. Beales M.P., Funderburgh J.L., Jester J.V., and Hassell J.R. Proteoglycan synthesis by bovine keratocytes and corneal fibroblasts: maintenance of the keratocyte phenotype in culture. Invest. Ophthalmol. Vis. Sci. 40 (1999) 1658-1663
4. Berton A., Levi-Schaffer F., Emonard H., Garbuzenko H., Gillery P., and Maquart F.X. Activation of fibroblasts in collagen lattices by mast cell extract: a model of fibrosis. Clin. Exp. Allergy 30 (2000) 485-492
5. Bocchini V., and Angeletti P.U. The nerve growth factor: purification as a 30,000-molecular-weight protein. Proc. Natl. Acad. Sci. U.S.A. 64 (1969) 787-794
6. Bonini S., Lambiase A., Rama P., Caprifoglio G., and Aloe L. Topical treatment with nerve growth factor for neurotrophic keratitis. Ophthalmology 107 (2000) 1347-1351
7. Boyle M.D., Lawman M.J., Gee A.P., and Young M. Nerve growth factor: a chemotactic factor for polymorphonuclear leukocytes in vivo. J. Immunol. 134 (1985) 564-568
8. Frank S., Madlener M., and Werner S. Transforming growth factors β1, β2, and β3 and their receptors are differentially regulated during normal and impaired wound healing. J. Biol. Chem. 271 (1996) 10188-10193
9. Green L.A. A quantitative bioassay for nerve growth factor (NGF) activity employing a clonal pheochromocytoma cell line. Brain Res. 133 (1977) 350-353
10. Imanishi J., Kamiyama K., Iguchi I., Kita M., Sotozono C., and Kinoshita S. Growth factors: importance in wound healing and maintenance of transparency of the cornea. Prog. Retinal Eye Res. 19 (2000) 113-129
11. Hao J.L., Suzuki K., Lu Y., Hirano S., Fukuda K., Kumagai N., and Nishida T. Inhibition of gap junction-mediated intercellular communication by TNF-α in cultured human corneal fibroblasts. Invest. Ophthalmol. Vis. Sci. 46 (2005) 1195-1200
12. Jester J.V., and Ho-Chang J. Modulation of cultured corneal keratocyte phenotype by growth factors/cytokines control in vitro contractility and extracellular matrix contraction. Exp. Eye Res. 77 (2003) 581-592
13. β-mediated corneal myofibroblast differentiation requires actin and fibronectin assembly. Invest. Ophthalmol. Vis. Sci. 40 (1999) 1959-1967
14. Joyce N.C., Meklir B., Joyce S.J., and Zieske J.D. Cell cycle protein expression and proliferative status in human corneal cells. Invest. Ophthalmol. Vis. Sci. 37 (1996) 645-655
15. Kasemkijwattana C., Menetrey J., Bosch P., Somogyi G., Moreland M.S., Fu F.H., Buranapanitkit B., Watkins S.S., and Huard J. Use of growth factors to improve muscle healing after strain injury. Clin. Orthop. 370 (2000) 272-285
16. Khan K.M.F., Falcone D.J., and Kraemer R. Nerve Growth Factor activation of erk-1 and erk-2 induces matrix metalloproteinases-9 expression in vascular smooth muscle cells. J. Biol. Chem. 277 (2002) 2353-2359
17. Lambiase A., Bonini S., Micera A., Rama P., Bonini S., and Aloe L. Expression of NGF receptors on ocular surface in healthy subjects and during manifestation of inflammatory diseases. Invest. Ophthalmol. Vis. Sci. 39 (1998) 1272-1275
18. Lambiase A., Rama P., Bonini S., Caprifoglio G., and Aloe L. Topical treatment with nerve growth factor for corneal neurotrophic ulcers. N. Engl. J. Med. 338 (1998) 1174-1180
19. Lambiase A., Manni L., Bonini S., Rama P., Micera A., and Aloe L. Nerve growth factor promotes corneal healing: structural, biochemical and molecular analysis of rat and human corneas. Invest. Ophthalmol. Vis. Sci. 41 (2000) 1063-1069
20. Lambiase A., Bonini S., Aloe L., and Rama P. Anti-inflammatory and healing properties of nerve growth factor in immune corneal ulcers with stromal melting. Arch. Ophthalmol. 118 (2000) 1446-1449
21. Lambiase A., Micera A., Sgrilletta R., Bonini Se., and Bonini St. Nerve growth factor and the immune system: old and new concepts in the cross-talk between immune and resident cells during pathophysiological conditions. Curr. Opin. Allergy Clin. Immunol. 4 (2004) 425-430
22. Levi-Schaffer F., and Kupietzky A. Mast cells enhance migration and proliferation of fibroblasts into an in vitro wound. Exp. Cell. Res. 188 (1990) 42-49
23. Li A.K., Koroly M.J., Schattenkerk M.E., Malt R.A., and Young M. Nerve growth factor: acceleration of the rate of wound healing in mice. Proc. Natl. Acad. Sci. U.S.A. 77 (1980) 4379-4381
24. Ling E.M., and Robinson D.S. Transforming growth factor-β1: its anti-inflammatory and pro-fibrotic effects. Clin. Exp. All. 32 (2002) 175-178
25. Lutz M., Krieglstein K., Schmitt S., ten Dijke P., Sebald W., Wizenmann A., and Knaus P. Nerve growth factor mediates activation of the Smad pathway in PC12 cells. Eur. J. Biochem. 271 (2004) 920-931
26. Matsuda H., Koyama H., Sato H., Sawada J., Itakura A., Tanaka A., Matsumoto M., Konno K., Ushio H., and Matsuda K. Role of nerve growth factor in cutaneous wound healing: accelerating effects in normal and healing-impared diabetic mice. J. Exp. Med. 187 (1998) 297-306
27. Micera A., Vigneti E., Pickholtz D., Reich R., Pappo O., Bonini S., Maquart F.X., Aloe L., and Levi-Schaffer F. Nerve growth factor displays stimulatory effects on human skin and lung fibroblasts, demonstrating a direct role for this factor in tissue repair. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 6162-6167
28. Micera A., Puxeddu I., Aloe A., and Levi-Schaffer F. New insights on the involvement of nerve growth factor in allergic inflammation and fibrosis. Cytokine Growth Factor Rev. 14 (2003) 369-374
29. Micera A., Lambiase A., Aloe L., Bonini Se., Levi-Schaffer F., and Bonini St. Nerve growth factor involvement in the visual system: implications in allergic and neurodegenerative diseases. Cytokine Growth Factor Rev. 15 (2004) 411-417
30. Micera A., Puxeddu I., Lambiase A., Aloe L., Bonini Se., Bonini St., Pe'er J., and Levi-Schaffer F. The pro-fibrogenic effect of nerve growth factor on conjunctival fibroblasts is mediated by transforming growth factor-β. Clin. Exp. All. 35 (2005) 650-656
31. Pfaffl M.W., Horgan G.W., and Dempfle L. Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res. 30 (2002) e36
32. Schultz G., Khaw P.T., Oxford K., MaCauley S., Van Setten G., and Chegini N. Growth factors and ocular wound healing. Eye 8 (1994) 184-187
33. Shubayen V.I., and Myers R.R. Matrix metalloproteinases-9 promotes nerve growth factor-induced neurite elongation but not new sprout formation in vitro. J. Neurosci. Res. 77 (2004) 229-239
34. Stamekovic I. Extracellular matrix remodelling: the role of matrix metalloproteinases. J. Pathol. 200 (2003) 448-464
35. Tomasek J.J., Gabbiani G., Hinz B., Chaponnier C., and Brown R.A. Myofibroblasts and mechano-regulation of connective tissue remodeling. Nat. Rev. Mol. Cell. Biol. 3 (2002) 349-363
36. Visse R., and Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases. Structure, function and biochemistry. Circ. Res. 92 (2003) 827-839
37. Weskamp G., and Otten U. An enzyme-linked immunoassay for nerve growth factor (NGF): a tool for studying regulatory mechanisms involved in NGF production in brain and in peripheral tissues. J. Neurochem. 48 (1987) 1779-1786
38. Wilcox R.R. New Statistical Procedures for the Social Sciences: Modern Solutions to Basic Problems (1987), Lawrence Erlbaum Associates, Hillsdale, NJ
39. Wilson S.E., Liu J.J., and Mohan R.R. Stromal-epithelial interactions in the cornea. Prog. Retin. Eye Res. 18 (1999) 293-309
40. Wilson S.E., Mohan R.R., Ambrosio Jr. R., Hong J., and Lee J. The corneal wound healing response: cytokine-mediated interaction of the epithelium, stroma, and inflammatory cells. Prog. Retin. Eye Res. 20 (2001) 625-637
41. Ye H.Q., and Azar D.T. Expression of gelatinases A and B, and TIMPs1 and2 during corneal wound healing. Invest. Ophthalmol. Vis. Sci. 39 (1998) 913-921
42. You L., Kruse F.E., and Volcker H.E. Neurotrophic factors in the human cornea. Invest. Ophthalmol. Vis. Sci. 41 (2000) 692-702